Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
61
CIMA_AEMPS:43
NMPA:10
EMA:8
Drug Approvals
Velaglucerase Alfa for Injection
- Product Name
- 维葡瑞
- Approval Number
- 国药准字SJ20210013
- Approval Date
- Apr 27, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171353
- Approval Date
- Apr 8, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171351
- Approval Date
- Apr 8, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171356
- Approval Date
- Apr 8, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171354
- Approval Date
- Apr 8, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171355
- Approval Date
- Apr 8, 2021
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 福斯利诺
- Approval Number
- 国药准字HJ20171352
- Approval Date
- Apr 8, 2021
NMPA
Icatibant Acetate Injection
- Product Name
- 醋酸艾替班特注射液
- Approval Number
- 国药准字HJ20210024
- Approval Date
- Apr 7, 2021
NMPA
Agalsidase Alfa Concentrated Solution for Infusion
- Product Name
- 瑞普佳
- Approval Number
- 国药准字SJ20200021
- Approval Date
- Aug 26, 2020
NMPA
Clinical Trials
No trials found
News
No news found